From this analysis, we conclude that AL117190.1, COL4A2‐AS1, LINC00184, MEG3 and MIR22HG act as prognostic biomarkers, whose low expression revealed that patients with breast cancer have better overall survival. This evidence concerns the gene MIR22HG and breast carcinoma.